The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoALTTO study.

Autor: Di Cosimo, Serena1 (AUTHOR), Triulzi, Tiziana1 (AUTHOR), Pizzamiglio, Sara1 (AUTHOR), De Cecco, Loris1 (AUTHOR), de Azambuja, Evandro2 (AUTHOR), Fumagalli, Debora3 (AUTHOR), Putzai, Lajos4 (AUTHOR), Harbeck, Nadia5 (AUTHOR), Izquierdo, Miguel6 (AUTHOR), Peña, Lorena de la7 (AUTHOR), Daidone, Maria Grazia1 (AUTHOR), Huober, Jens8 (AUTHOR), Gori, Stefania9 (AUTHOR), Cinieri, Saverio10 (AUTHOR), Torri, Valter11 (AUTHOR), Baselga, Jose7 (AUTHOR), Piccart, Martine2 (AUTHOR), de Braud, Filippo G.1 (AUTHOR), Apolone, Giovanni1 (AUTHOR), Verderio, Paolo1 (AUTHOR)
Zdroj: European Journal of Cancer. Sep2019, Vol. 118, p1-9. 9p.
Databáze: Academic Search Ultimate
Externí odkaz: